| Application no. and date | 09810708.9 (espacenet) (Federated) (European Patent Register), 20090829 | | Patent/reg. no. and date | DK/EP 2337575, 20160413 | | Publication date | 20110629 | | Priority no. and date | US 93314 P, 20080830, US 93497 P, 20080902 | | EP pub. no. and date |
EP 2337575 20110629 | | Effective date | | | Applicant/owner | The Medicines Company, 8 Sylvan Way
Parsippany, NJ 07054, US | | Applicant ref. no. | P58549DK01 | | Inventor | MOECK, Gregory, 845 Rue Lindsay
St. Laurent, Québec H4L 2R3, CA,
LEHOUX, Dario, 61 rue de Plaisance
Terrebonne, Québec J6Y 0C9, CA,
PARR, Thomas R., 10715 Hunters Cove Drive
Indianapolis, Indiana 46236, US,
ETIENNE, Pierre, 1179 de Bleury 11
Montreal, Québec H3B 3H9, CA | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 38/14 (2006.01) , A61P 17/00 (2006.01) , A61P 31/04 (2006.01) | | Title | Fremgangsmåde til behandling med enkeltdoser af oritavancin | | Int. application no. | US2009055466 | | Int. publication no. | WO2010025438 | | Related patent (certificate) | CA 2016 00044 | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
